Aer Therapeutics key facts
as of Oct 2026- Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs.
- Aer Therapeutics is valued at approximately $58.0M as of Oct 2026, set at a debt round, Mar 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $48.0M across 2 recorded rounds; the latest was Early Stage VC ($5.0M) in Jan 2025.
- Notable investors include National Institutes of Health, OrbiMed, Canaan Partners, Hatteras Venture Partners, NovaUCD — 6 tracked in total.
- Aer Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently Feb 2025 ($5.0M sold to 15 investors).
- Status: Privately Held (backing).
Valued at $58.0M at a debt round, Mar 2025. Nothing has traded since.
- ·Watch Aer Therapeutics: the Monday email on marks, rounds and moves
Aer Therapeutics funding rounds
2 roundsWho backs Aer Therapeutics
6Aer Therapeutics valuation
Aer Therapeutics was valued at $58 million at a debt round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Aer Therapeutics raised?
Aer Therapeutics has raised $48 million in total; 2 of its rounds are on record. The largest on record was a $5 million early-stage round in Jan 2025.
Aer Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Feb 2025 ($5 million sold to 15 investors).
Aer Therapeutics investors
6 investors are on record for Aer Therapeutics, including National Institutes of Health, OrbiMed, Canaan Partners and Hatteras Venture Partners. The early-stage round in Jan 2025 drew 15 investors.
About Aer Therapeutics
Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with unmet needs, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, enabling researchers to advance the treatment paradigm for mucus-mediated lung diseases.
- Sector
- Healthcare
- HQ
- Durham, United Kingdom
- Founded
- 2014
- Employees
- 10
- Website
- aertherapeutics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.